We appreciate Dr. Kim and Professor Kim for their interest and comments on our article entitled "The risk of diabetes on clinical outcomes in patients with coronavirus disease 2019: a retrospective cohort study" published in *Diabetes & Metabolism Journal* \[[@B1]\].

South Korea experienced a massive outbreak of coronavirus disease 2019 (COVID-19) in February 2020; 52% of all confirmed cases and 66% of deaths occurred in Daegu City \[[@B2]\]. According to the data published to date, COVID-19 fatalities were prevalent in patients with comorbid diabetes; however, whether diabetes is a risk factor for death remains unclear \[[@B3][@B4][@B5]\]. Diabetes was shown as an independent risk factor for severe and critical outcomes (composite outcomes of acute respiratory distress syndrome, septic shock, intensive care unit care, and 28-day mortality) in COVID-19 patients after adjusting for other risk factors.

Among patients with diabetes, old age significantly increased the risk of severe and critical outcomes; however, glycosylated hemoglobin (HbA1c) and serum glucose levels did not. Long-term glycemic control (HbA1c) has not been identified as a significant predictor of COVID-19 prognosis and death \[[@B6]\]; however, well-controlled blood glucose (≤180 mg/dL) during hospitalization resulted in a better outcome \[[@B7]\]. Regardless of HbA1c level, proper blood glucose control during hospitalization (140 to 180 mg/dL) might improve the prognosis of COVID-19 \[[@B8]\].

Contrary to concerns, anti-hyperglycemic agents or renin-angiotensin system (RAS) inhibitors did not significantly affect the severity of COVID-19. To date, whether RAS inhibitors affect the prognosis of COVID-19 is unclear, and dipeptidyl peptidase-4 inhibitors showed a neutral effect \[[@B6][@B9]\]. In our opinion, the existing drugs should be continued for mild to moderate COVID-19 patients, and in severe patients, insulin is most suitable for glycemic control \[[@B10]\].

Finally, we thank the editor-in-chief of the *Diabetes & Metabolism Journal* and all the readers who showed interest in our research.
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